Evotec AG, of Hamburg, Germany, and the Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute in Boston disclosed a research collaboration aimed at discovering and commercializing cancer treatments based on epigenetic drug mechanisms

AmorChem, of Montreal, and InflammatorRx Inc., of Quebec City, said they launched a research collaboration in inflammatory and autoimmune diseases

GE Healthcare, of Chalfont St. Giles, UK, and Eisai Inc., of Woodcliff Lake, N.J., inked a research collaboration agreement for use of the GE Healthcare investigational PET amyloid imaging agent

Evotec AG, of Hamburg, Germany, and the Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute in Boston disclosed a research collaboration aimed at discovering and commercializing cancer treatments based on epigenetic drug mechanisms

GE Healthcare, of Chalfont St. Giles, UK, and Eisai Inc., of Woodcliff Lake, N.J., inked a research collaboration agreement for use of the GE Healthcare investigational PET amyloid imaging agent

to begin a Phase IIa trial of BL-8040, a selective antagonist of chemokine receptor CXCR4, in acute myeloid leukemia (AML...According to the terms, Shasun will be able to use the Debiopharm technology to manufacture synthetic Huperzine-A under GMP quality conditions and commercialize it in pharmaceutical and nutraceutical markets...In other news, GSK experienced manufacturing delays for manufacture and supply of Horizant (gabapentin enacarbil), partnered with XenoPort Inc., of Santa Clara, Calif

PeptiDream Inc., of Tokyo, and Ipsen SA, of Paris, entered a research collaboration and license option agreement to discover, evaluate, potentially develop and launch therapeutic peptides to treat serious medical conditions in areas of therapeutic focus for Ipsen

Oncodesign SA, of Dijon, France, signed a second research collaboration agreement with Sanofi SA, of Paris, following a deal last year related to kinase targets under development by Sanofi

KineMed Inc., of Emeryville, Calif., said it renewed a nonexclusive research collaboration with Pfizer Inc., of New York, to advance approaches for treating metabolic disease, in particular Type II diabetes

DART Therapeutics Inc., of Cambridge, Mass., entered a research collaboration with Biovista Inc., of Charlottesville, Va., to identify and develop drug repositioning candidates for Duchenne's muscular dystrophy using Biovista's Clinical Outcome Search Space technology...Oncodesign SA, of Dijon, France, signed a second research collaboration agreement with Sanofi SA, of Paris, following a deal last year related to kinase targets under development by Sanofi

Fibrocell Science Inc., of Exton, Pa., said its research collaboration with the University of California, Los Angeles, resulted in a discovery that may lead to a more predictable commercially viable method of producing stable induced pluripotent stem cells from adult skin cells

Takeda Pharmaceutical Co., of Tokyo, and the Scripps Research Institute announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases

Clinigen Group plc, of Burton-on-Trent, UK, and Theravance Inc., of South San Francisco, entered an exclusive commercialization agreement in the European Union and certain other countries located in Europe for Vibativ (telavancin) in nosocomial pneumonia, including ventilator-associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus, when other alternatives are not suitable...In other news, Elan said its Tysabri (natalizumab) restructuring transaction is

Riboxx Pharmaceuticals GmbH, of Radebeul, Germany, began a research collaboration with China National Biotech Group Co

Ablynx NV, of Ghent, Belgium, and Spirogen Ltd., of London, inked a research collaboration to evaluate the potential of a cancer drug conjugate combining Spirogen's cytotoxic drugs, pyrrolobenzodiazepines and associated linker technology, with Nanobodies generated using Ablynx's technology platform

CytoDyn Inc., of Portland, Ore., said it entered a research collaboration with the Scripps Research Institute to study the firm's humanized anti-CCR5 antibody, PRO 140, in a pre-exposure prophylaxis model of HIV infection

Ablynx NV, of Ghent, Belgium, and Spirogen Ltd., of London, inked a research collaboration to evaluate the potential of a cancer drug conjugate combining Spirogen's cytotoxic drugs, pyrrolobenzodiazepines and associated linker technology, with Nanobodies generated using Ablynx's technology platform

The licensing deal follows a research collaboration between the two organizations

NeurOp Inc., of Atlanta, said it formed a research collaboration with Emory University, also of Atlanta, to study modulation of certain brain cell receptors and its possible impact on several serious cognitive and mental health disorders such as schizophrenia, post-traumatic stress disorder, Parkinson's disease and Alzheimer's disease